Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 17, 2013
BioStorage Technologies, a global provider of comprehensive sample management solutions for the bioscience industry, today announced that the company's U.S. biorepository facility has received accreditation from the College of American Pathologists (...
read more
INDIANAPOLIS, March 19, 2012 /PRNewswire/ -- BioStorage Technologies, a global provider of comprehensive sample management solutions, biomaterial storage and cold chain logistics for the bioscience industry, announced today that it will host a live, ...
read more
BioStorage Technologies, a global provider of comprehensive sample management solutions for the bioscience industry, including storage, cold chain logistics and virtual sample intelligence, will host its European Global Sample Management Benchmarking...
read more
BioStorage Technologies, a global provider of comprehensive sample management solutions for the bioscience industry, including storage, cold chain logistics and virtual sample intelligence, has announced the appointment of Kristina Robson, Ph.D., as ...
read more
Thursday, October 27, 2016
BioStorage Technologies, Inc. a provider of comprehensive sample lifecycle management for the life sciences industry and subsidiary of Brooks Life Science Systems, has announced the expansion of its sample storage services in the U.S. and ...
read more
Biosynth, a supplier of raw materials to the life science industry, has acquired celares, a developer and manufacturer of conjugate vaccines and bioconjugate drugs, activated PEGs, and polymer-based drug delivery excipients.
read more
Tuesday, November 09, 2021
Biosynth Carbosynth and Shengquan announced their acquisition of Kexing Biopharmaceutical's raw material factory in Jinan, China.
read more
Biosynth announced the opening of its expanded GMP bioconjugation facility at its existing Berlin site. This strategic expansion significantly enhances Biosynth's specialized manufacturing capabilities in conjugate vaccines and conjugate drugs, ...
read more
Monday, September 25, 2023
Biosynth, a supplier of critical materials to the life science industry, is pleased to announce the acquisition of Pepceuticals, a UK producer of synthetic peptides with multi-kilogram GMP facilities and fill-finish capabilities designed to support ...
read more
Tuesday, October 03, 2023
Biosynth, a supplier of critical materials to the life science industry, is pleased to announce the acquisition of Pepceuticals, a UK producer of synthetic peptides with multi-kilogram GMP facilities and fill-finish capabilities designed to support ...
read more
Biosynth has acquired Cambridge Research Biochemicals (“CRB”), a producer of custom-made peptide and antibody tools, based in the UK and supplying researchers in the pharmaceutical, life science and academic sectors.
read more
BIOTEM announced the implementation of a new industrial site in Colombe, Isère, located just over a mile (2km) from its current site.
read more
Tuesday, January 15, 2013
Biotest Pharmaceuticals Corp. (BPC), a wholly owned U.S. subsidiary of Biotest AG (Dreieich, Germany), today announced it has entered into a strategic long-term manufacturing, supply, and license agreement with ADMA Biologics,Inc.(ADMA).
read more
Saturday, January 28, 2017
Biotest Pharmaceuticals Corporation has announced the relocation of its Gainesville plasma collection center to 2315 NW 13th Street, Gainesville, Florida. The 15,000 square foot state-of-the-art facility officially opened its doors for business on ...
read more
Wednesday, December 07, 2016
Biothera Pharmaceuticals has announced an expansion of its research collaboration with Merck (known as MSD outside the United States and Canada) to include a Phase 2 clinical study investigating Biothera’s Imprime PGG in combination with KEYTRUDA® (...
read more